Information provided by the nominee

Realizing the value creation playbook and high-conviction investment strategy, the fund achieved an overall return of 3,5x  and 42% IRR  (incl. follow-on investments). Since the initial pre-seed investment, the company raised €5,5M Series A. Number of patients supported grew from  40k to 3M yearly. Telemedi revenue grew since the initial investment to exit by 2465%.